Carol Suh

Carol Suh

Fondatore presso
Orbital Therapeutics, Inc.
35 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Carol Suh was the founder of Neumora Therapeutics, Inc., founded in 2019, where the title held was Chief Strategy Officer from 2025 to 2026.
Ms. Suh is the founder of Orbital Therapeutics, Inc., founded in 2022, holding the title of Director since 2022.
Current jobs include Director at Metrodora SL since 2021, Director at Human Immunology Biosciences, Inc. since 2021, and Partner at ARCH Venture Partners LLC since 2018.
Former jobs include Director at HIBio, Inc., Consultant at Trinity Partners LLC from 2015 to 2016, and Associate-Business Development & Strategy at Magenta Therapeutics, Inc. in 2017.
Education history includes undergraduate studies at Harvard University, graduate studies at Yale University, and an MBA from Stanford Graduate School of Business.

Posizioni attive di Carol Suh

SocietàPosizioneInizio
Investitore di Private Equity 01/07/2021
Direttore/Membro del Consiglio 01/08/2021
Fondatore 01/03/2022
Direttore/Membro del Consiglio 01/10/2021

Precedenti posizioni note di Carol Suh

SocietàPosizioneFine
NEUMORA THERAPEUTICS, INC. Fondatore 01/02/2026
MAGENTA THERAPEUTICS Corporate Officer/Principal 01/09/2017
Consulente / Consigliere 01/05/2016
Direttore/Membro del Consiglio -
Vedi nel dettaglio l'esperienza di Carol Suh

Formazione di Carol Suh

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

66

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Finance

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology